Differences in epidemiology of candidaemia in the Nordic countries - what is to blame?
about
Potential Use of MALDI-ToF Mass Spectrometry for Rapid Detection of Antifungal Resistance in the Human Pathogen Candida glabrataDiabetic foot infection: Antibiotic therapy and good practice recommendations.Update from a twelve-year nationwide fungaemia surveillance: increasing intrinsic and acquired resistance causes concern.An Estimate of the Burden of Fungal Disease in Norway.
P2860
Differences in epidemiology of candidaemia in the Nordic countries - what is to blame?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Differences in epidemiology of candidaemia in the Nordic countries - what is to blame?
@en
Differences in epidemiology of candidaemia in the Nordic countries - what is to blame?
@nl
type
label
Differences in epidemiology of candidaemia in the Nordic countries - what is to blame?
@en
Differences in epidemiology of candidaemia in the Nordic countries - what is to blame?
@nl
prefLabel
Differences in epidemiology of candidaemia in the Nordic countries - what is to blame?
@en
Differences in epidemiology of candidaemia in the Nordic countries - what is to blame?
@nl
P2093
P2860
P356
P1433
P1476
Differences in epidemiology of candidaemia in the Nordic countries - what is to blame?
@en
P2093
Eira Poikonen
Ingvild Nordøy
Lena Klingpor
Liv Hesstvedt
Swedish fungal Surveillance Group Collaborators (16)
Vanda Friman
P2860
P356
10.1111/MYC.12535
P577
2016-07-28T00:00:00Z